Merten O W, Hannoun C, Manuguerra J C, Ventre F, Petres S
Laboratoire de Technologie Cellulaire, Institut Pasteur, Paris, France.
Adv Exp Med Biol. 1996;397:141-51. doi: 10.1007/978-1-4899-1382-1_19.
Influenza virus strains of different types for use as an inactivated vaccine have been successfully grown in different cell lines. Increasing titres were obtained with BHK-21/BRS, VERO and MDCK cells. Cultures in stationary flasks, in spinner cultures or in large bioreactor systems were tested and the optimal conditions were studied. MDCK cells grown in serum-free medium before and during the virus production phase were found to yield high titres in the presence of trypsin. Satisfactory results were obtained with egg-adapted strains of human and equine origin as well as with strains just isolated from human patients without any further passages in eggs or cell culture.
用作灭活疫苗的不同类型流感病毒株已在不同细胞系中成功培养。在BHK - 21/BRS、VERO和MDCK细胞中获得了不断提高的滴度。对固定瓶培养、转瓶培养或大型生物反应器系统中的培养物进行了测试,并研究了最佳条件。发现在病毒生产阶段之前和期间在无血清培养基中培养的MDCK细胞在胰蛋白酶存在下能产生高滴度。人源和马源的鸡胚适应株以及刚从人类患者分离出且未在鸡胚或细胞培养中进一步传代的毒株都取得了令人满意的结果。